Ascertain

What Ascertain does

Ascertain Systems, Inc. is a New York-based healthcare technology company (Delaware-incorporated) that develops an agentic AI platform for healthcare administrative automation. The platform autonomously ingests structured and unstructured healthcare data (clinical notes, payer portal content, faxes) and executes end-to-end administrative workflows including prior authorizations, eligibility checks, referrals, care coordination, denials management, and an AI voice agent capability. The company is positioned as 'born inside a major health system' (per company marketing) and integrates with existing EHRs, payer portals, and CRMs as a human user would, enabling bi-directional data flow without rip-and-replace.

The product strategy centers on a service-augmented SaaS model that combines autonomous AI agents with 'Ascertain Assistants' — healthcare-veteran operators with prior experience owning the workflows being automated — who provide human-in-the-loop review, exception handling, and auditable oversight. This hybrid model targets 4–6 week deployment timelines and ROI in under 90 days. The platform is organized as a core engine with a pre-built workflow catalog (prior auth, eligibility verification, denials/appeals, care planning, case management, utilization management, and others) sold to large health systems, specialty practices, MSOs, and health plans under a land-and-expand dynamic.

Financially, Ascertain closed a $10 million Series A in April 2025 led by Deerfield Management with strategic participation from Northwell Health, following an earlier SEC Regulation D exempt offering in March 2024 targeting approximately $10.9 million. Named customer relationships include Northwell Health (strategic pilot customer and investor) and The Oncology Institute (co-development partner for 'near-touchless' AI-driven administrative workflows for outpatient oncology, with reported metrics of 95% faster post-acute submissions across 100+ oncology clinics, 80% reduction in user clicks, 67% faster authorization submissions, and up to $2M in expected operational cost savings in 2026).

Name

Ascertain

Legal name

Ascertain Systems, Inc.

Website

https://ascertain.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

Ascertain Systems, Inc. is a New York-based healthcare AI company providing an agentic AI platform that automates administrative workflows (prior authorizations, eligibility, care coordination) for health systems, payers, and providers. It combines AI agents with healthcare-veteran operators in a human-in-the-loop model.

Ownership category

akta.pro rank

Product category

Healthcare Administration Automation Software

NAICS

Software Publishers (513210), Custom Computer Programming Services (541511)

SIC

Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)

akta.pro industry

PRIMARYHLACAEAJ

Adherence, Reminders & Engagement Automation (Medication/Follow-up)

Healthcare & Life Sciences/Digital Health & Health IT/Patient Engagement, CRM & Experience Platforms

SECONDARYHDAEAHAG

iBPMS (Intelligent BPM Suites) & Process Automation Suites

Hardware, Technology & Telecom/Enterprise Platforms & Databases/Business Process Management (BPM), Workflow & Automation Platforms

Keywords

• Healthcare administration automation
• Prior authorization software
• Agentic AI platform
• Revenue cycle automation
• Care management workflow

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Enterprise SaaS subscription: Ascertain sells its agentic AI automation platform to healthcare enterprises (health systems, specialty practices, MSOs, health plans) under B2B SaaS agreements with land-and-expand dynamics, starting with a single workflow and scaling across revenue cycle and care management.
2. Ascertain Assistants (managed services): Healthcare-veteran operators ("Ascertain Assistants") are engaged pre-sales, during implementation, and for ongoing support, providing a managed-services overlay on top of the software subscription.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Core offering

Ascertain sells an agentic AI platform that autonomously ingests structured and unstructured healthcare data and executes end-to-end administrative workflows — prior authorizations, eligibility verification, referral processing, denials management, care coordination, and care planning — across customers' existing EHRs, payer portals, and CRMs. The software is delivered with a human-in-the-loop service layer ("Ascertain Assistants") and is sold as enterprise SaaS to health systems, specialty practices, MSOs, and health plans, with stated deployment in 4–6 weeks and ROI in under 90 days.

Product overview

Ascertain offers a single unified agentic AI platform for healthcare administration, organized as one core platform with multiple workflow modules rather than a portfolio of separate products. The core Ascertain platform executes prior authorizations, referrals, eligibility checks, and care coordination across existing systems (EHRs, payer portals, CRMs) and is delivered through a phased Listen → Configure → Deploy → Scale methodology. The platform is operationalized by "Ascertain Assistants" (healthcare veterans) who support onboarding and ongoing operations. The modular workflow capabilities exposed by the platform include: Prior Authorization, Medical Records Request, Care Planning, Closing Care Gaps, AI Voice Agent, Denials Management, and Transportation (transportation-related coordination). Across the revenue cycle and care management, the platform additionally automates Eligibility Verification, Utilization Management, Case Management, Referral Processing, Discharge Planning, Referral Management, Care Planning, Compliance, Fax Ingestion, Claims Management, Care Gap Identification, Denials and Appeals, Population Health Management, Audit Readiness, and Care Coordination. The Ascertain Assistants service layer wraps the platform to handle onboarding, implementation, and routine support.

Differentiator

Problem solved

Functional benefit

Products and services

• Ascertain Platform (Agentic AI for Healthcare Administration) Core agentic AI platform that autonomously ingests structured and unstructured healthcare data (clinical notes, payer portal content, faxes) and executes end-to-end administrative workflows including prior authorizations, eligibility checks, referrals, care coordination, denials management, care planning, and utilization management across customers' existing EHRs, payer portals, and CRMs, with human-in-the-loop oversight. Sold as enterprise SaaS to health systems, specialty practices, MSOs, and health plans.
• Ascertain Assistants Service layer of healthcare-veteran operators with prior experience owning the workflows being automated; engaged pre-sales, during implementation, and for routine support of onboarded clients, providing human-in-the-loop oversight over the agentic AI platform.
• Touchless AI Automation for Oncology Administration Co-developed "near-touchless" AI-driven administrative workflow for outpatient oncology prior authorization with The Oncology Institute; first implementation went live in eight weeks, with reported reduction of authorization submission times from 350 hours to 10 and up to $2 million in operational cost savings expected in 2026 across 100+ oncology clinics.

Quantifiable outcome

• 95% faster post-acute submissions across 100+ oncology clinics at The Oncology Institute
• +5 more outcomes

Named customers3 records

Segments7 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature7 records

Partnerships

Two partnerships are on record, tiered flagship co-development partner and reference customer and reference customer and logo partner.

• The Oncology Institute (TOI)flagship co-development partner and reference customerStrategic or Co-development Partner · 13 November 2025Ascertain and The Oncology Institute publicly co-developed a 'near-touchless' AI-driven administrative workflow for outpatient oncology visits, announced via GlobeNewswire on November 13, 2025. The initial deployment reduced authorization submission times and is expected to save up to $2 million in operational costs in 2026. TOI's CEO Daniel Virnich provided a public testimonial, and the company is featured in the "Trusted and backed by" logo strip.
• Cardiovascular Associates of America (CVA)reference customer and logo partnerStrategic or Co-development PartnerCardiovascular Associates of America is featured in Ascertain's "Trusted and backed by" logo strip on the homepage, and its SVP of Innovation, Ben Diestel, provided a public testimonial describing deployment of Ascertain's agentic AI platform to scale administrative automation for cardiovascular care delivery.

Scale indicators10 records

Recent moves6 records

Expansion highlights3 records

Direct peers

• Cohere Health: Direct peer selling AI-driven prior authorization and utilization management workflow software to health plans and providers, with similar clinical+administrative workflow automation focus.
• Notable Health: Direct peer offering intelligent automation for administrative and clinical workflows in health systems, using AI to streamline tasks such as scheduling, authorizations, and care coordination.
• Hyro: Direct peer providing conversational and agentic AI for healthcare operations, including patient access, scheduling, and administrative call automation that overlaps with Ascertain's voice agent and care coordination modules.
• Nym: Direct peer that deploys autonomous AI agents to interpret clinical documentation and automate medical coding and administrative workflows for providers and payers, with a similar agentic-AI positioning and revenue-cycle focus.
• Infinitus: Direct peer that automates phone-based healthcare administrative calls (benefits verification, prior authorization status) using AI voice agents, competing head-on with Ascertain's voice agent and eligibility/prior auth modules.
• Anterior: Direct peer applying LLM-based clinical AI to prior authorization and clinical documentation, targeting health plans and providers with workflow automation that closely overlaps Ascertain's prior auth module.

Broad incumbents

• Waystar: Broad incumbent revenue cycle management platform that competes for the same healthcare admin budget, offering eligibility, prior authorization, denials, and claims workflows that Ascertain augments or replaces.
• Olive AI: Broad incumbent in healthcare AI-driven administrative automation across revenue cycle and operations; while the company has reset, its installed base and brand remain a comparable reference point for agentic admin automation in healthcare.
• Surescripts: Broad incumbent in healthcare data exchange and prior authorization, operating the widely adopted SCRIPT/NCPDP standards-based network; competes indirectly as an established prior-auth and eligibility rail for many Ascertain customers.

Emerging players

• Syllable: Emerging peer deploying AI agents for healthcare front-office and administrative call handling (scheduling, routing, patient intake), overlapping with Ascertain's voice agent and care coordination use cases for providers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat1 record

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ascertain-ai

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ascertain